Results

Total Results: 1,887 records

Showing results for "testing".

321. White Paper: Living Systematic Reviews: Practical Considerations for Adapting Scope and Communicating the Evolving Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/scope-communicating-evolving-evidence-white-paper_0.pdf
     June 01, 2025 - Opioids Pain Management Objective Testing Comparisons Monochromatic Infrared Photo Energy (MIRE); … A visual abstract based on our living review23 has been developed by the Systematically Testing the … Systematically Testing the Evidence on Marijuana (STEM). … Systematically Testing the Evidence on Marijuana (STEM) visual abstract 1. Background 2.

322. Implementing Evidence-Based Screening and Counseling for Unhealthy Alcohol-Use With Epic-Based Electronic Health Record Tools: A Guide for Clinics and Health Systems Developed as Part of a Pilot Dissemination Project (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/implementation-package-unhealthy-alcohol-use-final.pdf
     September 01, 2018 - providers and staff to optimize protocols, tools, and training procedures before implementing and testing … Key features of our development process included: • Testing low-tech tools and protocols before launching … completed in 5 minutes or less and has been tested extensively in primary care settings.3 In initial testing … • All team members received training in QI methods which facilitated development and testing. … Science of Improvement: Testing Changes. 2018.

323. Evidence Summary-Comparative-Effectiveness-Review-213-Lower-Limb-Prostheses (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-213-lower-limb-protheses-evidence-summary.pdf
     September 01, 2018 - Standards for psychometric testing have changed over the years, so older instruments, evaluated by

324. Disposition of Comments for CER 158 Diagnosis of Gout (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout-diagnosis-disposition-160727.pdf
     February 24, 2016 - Disposition of Comments for CER 158 Diagnosis of Gout Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Diagnosis of Gout Draft review available for public comment from November 4, 2014 to December 2, 2014. Research Review Citation: Newberry SJ, FitzGerald J, Maglione MA, O’…

325. AHRQ’s Evidence-based Practice Center Program Synthesizing evidence to improve health care practice and delivery (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/epc-synthesizing-evidence-improve.pdf
     July 01, 2020 - AHRQ’s Evidence-based Practice Center Program Synthesizing evidence to improve health care practice and delivery 1 EPC Program Methods for Systematic Reviews What is the Evidence-based Practice Center Program? The vision for AHRQ’s Evidence-based Practice Center (EPC) Program is that all health care decisions are…

326. Kidney-Disease-Medicine Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_executive.pdf
     January 01, 2012 - CKD stages 1–3 usually progress asymptomatically, detection of early-stage CKD requires laboratory testing … While it does not constitute direct evidence that testing patients with diabetes and hypertension for … This does not constitute direct evidence that testing patients with hyperlipidemia for eGFR will reduce … However, as patients with systolic CHF already have an indication for beta blocker treatment, testing … could include adverse effects from monitoring and followup tests, including potentially unnecessary testing

327. Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment in Children and Adolescents - Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/deficit-hyperactivity-protocol.pdf
     November 01, 2021 - conditions (e.g., depression or anxiety), family conflict, and biomarker status (e.g., genotype, cognitive testing … comorbid illnesses, and with which specific genotypes.21, 49-52 Recent advances in the development and testing … Neuropsychological Testing is Not Useful in the Diagnosis of ADHD: Stop It (or Prove It)! … Design of sequentially randomized trials for testing adaptive treatment strategies. … tova[tiab] OR "test of variables of attention"[tiab] OR neba[tiab] OR test[tiab] OR tests[tiab] OR testing

328. Integrating Health System Data With Systematic Reviews_Methods Research Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-research-report-integrating-health-system-data.pdf
     April 01, 2020 - They therefore requested that CEP conduct a review of published studies that evaluated diagnostic testing … The resulting review informed development of a new testing algorithm. … Pilot testing of these approaches is currently underway in Penn Medicine clinics. … specific gaps in evidence.25 This report informed a request for proposals for studies of pharmacogenomic testing … set of examples inclusive of more complex interventions (e.g., systems based interventions), medical testing

329. Disposition of Comments_Technical Brief 52: Pediatric Quality Measures Program 3.0: An Evidence Map of Measures for Vision, Hearing, and Developmental Screening and Followup (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pqmp-disposition-comments.pdf
     April 07, 2025 - Certain insurances may also more proactively incentivize clients to pursue specific testing with rewards … While FDA approvals are extremely important for screening testing tools for visual acuity or hearing … testing/screening, we are not aware of their involvement in the approval process for the development … measures with compiled information on reliability, validity, usability, and feasibility testing results … We used “visual acuity screen”, instead of “visual acuity testing” to mirror the exact language as

330. Disposition of Comments for CER 153 Non-Muscle-Invasive Bladder Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_disposition-comments.pdf
     October 27, 2015 - any studies evaluating effects of differences in cystoscopy or cytology intervals of duration of testing … We revised p 18 line 43-44 to be clearer that we were referring to testing for initial diagnosis of … This is to distinguish it from testing for purposes of surveillance following TURBT. … e) Improve patient compliance with accurate, non-invasive testing.

331. Disposition of Comments for Efficacy and Safety of Screening for Postpartum Depression (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-postpartum-screening_disposition-comments.pdf
     May 01, 2013 - We have added a reference to the use of serial testing in the Yawn paper, but cannot make direct comparisons … misleading when it is followed by statements of the range of cutpoints and lack of description of testing … Section Comment Response Peer Reviewer 3 General -A two-question test with follow-up diagnostic testing

332. Renal-Cancer Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-cancer_research-protocol.pdf
     April 20, 2015 - Despite the shortcomings in diagnostic testing, management decisions are made based on estimations of

333. Bladder-Cancer-Non-Muscle-Invasive Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_executive.pdf
     October 01, 2015 - The large number of available tests and testing strategies, and potential tradeoffs in diagnostic accuracy … , risks, and patient preferences pose significant challenges in determining optimal testing and monitoring … We also evaluated adverse effects of diagnostic testing (e.g., false- positives, labeling, anxiety, … but for quantitative NMP22 there was no clear difference in diagnostic accuracy based on reason for testing … In addition, prior reviews did not evaluate potential differences in diagnostic accuracy for testing

334. - (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_appendixes.pdf
     January 01, 2009 - 1992 4 N=109 Patients with CF aged 7 to 35, who underwent pulmonary function and exercise testing … 1992 4 N=109 Patients with CF aged 7 to 35, who underwent pulmonary function and exercise testing … 1992 4 N=109 Patients with CF aged 7 to 35, who underwent pulmonary function and exercise testing … The prognostic value of exercise testing in patients with cystic fibrosis. … Exercise testing and prognosis in adult cystic fibrosis. Thorax 1997;52(3):291-293. 11.

335. Chapter 12: Systematic Review of Prognostic Tests | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/methods-guidance-tests-prognostic/methods

336. Outcome Measure Framework Design Document (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/registry-of-patient-registries_research-2014.pdf
     January 01, 2014 - requirements for the OMF were gathered and refined through in-person meetings and user acceptance testing … .................................................................................4 User Acceptance Testing … Stakeholders participating in user acceptance testing, by type ...................................... … design for the OMF and presented this design to stakeholders through a series of user acceptance testing … Stakeholders participating in user acceptance testing, by type Incorporation of Stakeholder Feedback

337. Ch 1-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_1-user-guide-to-ocer_130129.pdf
     August 13, 2012 - If the FDA approves, human testing for safety and efficacy can begin. … The first phase of human testing is usually conducted in a limited number of healthy volunteers (phase … most decisions about the comparative effectiveness of interventions will not need such extensive testing … Hypothesis testing The first stages (i.e., descriptive analysis, hypothesis generation, and feasibility … Instead, these stages provide preliminary evidence or feasibility testing before larger, more resource-intensive

338. Disposition of Comments_Comparative Effectiveness Review No. 271, Treatments for Maternal Mental Health Conditions (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-271-mental-health-pregnant-disposition-comments.pdf
     July 31, 2024 - One RCT testing psychodynamic therapy did not have sufficient comparisons to be fully- extracted but … We coded studies as testing an IPT intervention if they referenced IPT principles and aimed to treat … Unfortunately, many studies testing psychodynamic or parent-infant interventions did not meet the … In our subgroup analyses of the studies testing CBT vs TAU and IPT vs TAU, we found no difference in … Unfortunately, only one study testing EMDR for perinatal individuals with PTSD met the inclusion criteria

339. S96 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s96.pdf
     October 01, 2007 - sex (100%), primary diagnosis (93%), implicated drugs (93%), primary treatments (80%), and diagnostic testing … Additional information on clinical testing, diagnosis, treatment, and patient disposition is also recorded … Less agreement was seen for diagnostic testing (0.61), drug frequency (0.68), and duration of therapy … described in ED medical record 10,277 99 Treatment described in ED medical record 9435 91 Diagnostic testing

340. Slide 1
     effectivehealthcare.ahrq.gov/sites/default/files/sensitivity-analysis-chapter-11.pptx
     January 01, 2013 - When results of analyses are consistent or unchanged by testing variations on underlying assumptions, … When the results of analyses are consistent or unchanged by testing variations on underlying assumptions … the data source or population under study), and modeling (modifying a variable’s functional form or testing